Acadia Pharmaceuticals Inc (ACAD):企業の財務・戦略的SWOT分析

◆英語タイトル:Acadia Pharmaceuticals Inc (ACAD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH66258FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Acadia Pharmaceuticals Inc (ACAD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Acadia Pharmaceuticals Inc (Acadia) discovers, develops and commercializes small molecule drugs for the treatment of central nervous system (CNS) disorders. The company’s marketed product Nuplazid (pimavanserin) is an FDA approved drug for the treatment of Parkinson’s disease psychosis. The company’s pipeline includes pimavanserin for the treatment of various indications which include Schizophrenia, Major Depressive Disorder (MDD), dementia-related psychosis (DRP), and trofinetide for the treatment of Rett Syndrome. The company markets its product in the US. It has operational presence in Denmark, Switzerland and the UK. Acadia is headquartered in San Diego, California, the US.

Acadia Pharmaceuticals Inc Key Recent Developments

Mar 31,2021: Geisinger Health, Acadia partner to build new facilities in Pennsylvania
Feb 24,2021: Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 19,2021: Acadia Pharmaceuticals recognizes National Caregiver’s Day with launch of MoreThanMemoryLoss.com
Feb 10,2021: Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
Jan 27,2021: Acadia Pharmaceuticals announces Commercial Leadership Change

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Acadia Pharmaceuticals Inc – Key Facts
Acadia Pharmaceuticals Inc – Key Employees
Acadia Pharmaceuticals Inc – Key Employee Biographies
Acadia Pharmaceuticals Inc – Major Products and Services
Acadia Pharmaceuticals Inc – History
Acadia Pharmaceuticals Inc – Company Statement
Acadia Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Acadia Pharmaceuticals Inc – Business Description
Acadia Pharmaceuticals Inc – Corporate Strategy
Acadia Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Acadia Pharmaceuticals Inc – Strengths
Acadia Pharmaceuticals Inc – Weaknesses
Acadia Pharmaceuticals Inc – Opportunities
Acadia Pharmaceuticals Inc – Threats
Acadia Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acadia Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 31, 2021: Geisinger Health, Acadia partner to build new facilities in Pennsylvania
Feb 24, 2021: Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Feb 19, 2021: Acadia Pharmaceuticals recognizes National Caregiver’s Day with launch of MoreThanMemoryLoss.com
Feb 10, 2021: Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
Jan 27, 2021: Acadia Pharmaceuticals announces Commercial Leadership Change
Nov 04, 2020: Acadia Pharmaceuticals reports third quarter 2020 financial results
Nov 04, 2020: Acadia Pharmaceuticals to Announce Third Quarter 2020 Financial Results on November 4, 2020
Oct 06, 2020: Michael J. Fox Foundation and Acadia Pharmaceuticals partner to share resources and foster dialogue on cognitive changes and other non-motor symptoms in Parkinson’s disease
Oct 01, 2020: Acadia Pharmaceuticals appoints Elizabeth Garofalo, M.D. to Board of Directors
Aug 31, 2020: ACADIA Pharmaceuticals appoints Gudarz Davar, M.D., as Executive Vice President and Head of Research and Development
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Acadia Pharmaceuticals Inc, Key Facts
Acadia Pharmaceuticals Inc, Key Employees
Acadia Pharmaceuticals Inc, Key Employee Biographies
Acadia Pharmaceuticals Inc, Major Products and Services
Acadia Pharmaceuticals Inc, History
Acadia Pharmaceuticals Inc, Other Locations
Acadia Pharmaceuticals Inc, Subsidiaries
Acadia Pharmaceuticals Inc, Key Competitors
Acadia Pharmaceuticals Inc, Ratios based on current share price
Acadia Pharmaceuticals Inc, Annual Ratios
Acadia Pharmaceuticals Inc, Annual Ratios (Cont...1)
Acadia Pharmaceuticals Inc, Interim Ratios
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Acadia Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Acadia Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Acadia Pharmaceuticals Inc (ACAD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Medco Energi Internasional Tbk (MEDC):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Medco Energi Internasional Tbk (MedcoEnergi), a subsidiary of Encore Energy Pte. Ltd., is an integrated energy company. It explores for and develops oil and gas fields. The company provides energy related services such as power production, engineering procurement and construction (EPC), o …
  • Carl Zeiss Meditec AG (AFX):製品パイプライン分析
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, an integrated medical technology company which operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. It provides comprehensive packages of solutions for the diagnosis and treatment of ey …
  • Beckman Coulter, Inc.:企業のM&A・事業提携・投資動向
    Beckman Coulter, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beckman Coulter, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Matinas BioPharma Holdings Inc (MTNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform to deliver various molecules such as small m …
  • iVascular SLU:製品パイプライン分析
    Summary iVascular SLU (iVascular) designs, develops and manufactures advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. It offers portfolio of products in the fields of interventional cardiology, endovascular intervention and interventional neuroradio …
  • Johnson Matthey PLC:企業の戦略・SWOT・財務情報
    Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report Summary Johnson Matthey PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Discovery Inc (DISCA):企業の財務・戦略的SWOT分析
    Discovery Inc (DISCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Antrim Energy Inc. (AEN)-石油・ガス分野:企業M&A・提携分析
    Summary Antrim Energy Inc. (Antrim Energy) is an oil and gas exploration and production company. It conducts the acquisition, exploration, development and production of oil and natural gas properties. The company carries out its operations in the UK North Sea and Ireland. In UK, the company holds op …
  • GenMark Diagnostics Inc (GNMK):医療機器:M&Aディール及び事業提携情報
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • CONSOL Energy Inc.:企業のM&A・事業提携・投資動向
    CONSOL Energy Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CONSOL Energy Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Tri-County Rural Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Tri-County Rural Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Caterpillar Inc.:戦略・SWOT・企業財務分析
    Caterpillar Inc. - Strategy, SWOT and Corporate Finance Report Summary Caterpillar Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Black Stone Minerals LP (BSM):企業の財務・戦略的SWOT分析
    Summary Black Stone Minerals LP (Black Stone) is a mining and minerals exploration and development company that explores and produces mineral deposits. The company's services include participating on a working interest basis when economics are favorable, leasing minerals to exploration and productio …
  • Proactis Holdings Plc (PHD):企業の財務・戦略的SWOT分析
    Summary Proactis Holdings PLC (Proactis) is a technology company. The company develops and provides spend control and eprocurement solutions. It offers various solutions such as purchase-to-pay, eCommerce, source-to-contract, and global framework. It provides source-to-contract solutions for supplie …
  • JBS S.A.:企業のM&A・事業提携・投資動向
    JBS S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JBS S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Lantronix, Inc. (LTRX):企業の財務・戦略的SWOT分析
    Lantronix, Inc. (LTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Curetis NV (CURE)-医療機器分野:企業M&A・提携分析
    Summary Curetis NV (Curetis) is a medical device company that offers molecular diagnosis solutions. The company offers diagnostic systems developed with Unyvero platform for severe infectious diseases. Its products are used in rapid diagnosis for variety of cartridges, diseases such as pneumonia, im …
  • Shangri-La Asia Ltd:戦略・SWOT・企業財務分析
    Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cymbet Corp:電力:M&Aディール及び事業提携情報
    Summary Cymbet Corp (Cymbet) is a clean technology company that offers energy storage solutions for microelectronic systems. The company’s products include EnerChip, EnerChip solid state batteries, EnerChip bare die, EnerChip RTC and evaluation kits. Its devices offers new concept in energy storage …
  • State Atomic Energy Corporation Rosatom:企業の戦略的SWOT分析
    State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆